Quantcast
Channel: Becker's Spine Review
Viewing all articles
Browse latest Browse all 23847

NuVasive shares target price raised to $55 by Brean Capital: 4 quick facts

$
0
0

Brean Capital Equities research analysts increased their price objective on NuVasive shares from $53 to $55 in a research note, according to a Dakota Financial News report.


Viewing all articles
Browse latest Browse all 23847

Trending Articles